Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.
Press releases published on May 8, 2025
RAPT Therapeutics Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT” or the “Company”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel …
Cassava Reports Q1 2025 Financials Results, Provides Business Update
GlobeNewswire
·
May 8, 2025
License agreement and recent leadership appointments position Cassava to advance development of simufilam in TSC-related epilepsy $117.3 Million in Cash and Cash Equivalents at March 31, 2025 AUSTIN, Texas, May 08, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences …
Prime Medicine Reports First Quarter 2025 Financial Results and Provides Business Updates
GlobeNewswire
·
May 8, 2025
-- Initial data from Phase 1/2 trial of PM359 for p47phox CGD expected in 2025 -- -- IND and/or CTA for PM577 for Wilson’s Disease on-track for 1H 2026 -- -- Unveiled potentially best-in-class program for AATD; IND and/or CTA filing targeted for mid-2026 …
VYNE Therapeutics Reports 2025 First Quarter Financial Results and Provides Business Update
GlobeNewswire
·
May 8, 2025
Repibresib gel (VYN201) Phase 2b vitiligo top-line results expected in mid-2025 Expected cash runway into 2H 2026 BRIDGEWATER, N.J., May 08, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage …
Cue Biopharma to Host Virtual Investor Event on May 15, 2025
GlobeNewswire
·
May 8, 2025
Mobilizing the Immune System: Cue Biopharma's Novel Biologics Portfolio Event Virtual Event will Feature Key Opinion Leaders Richard DiPaolo, PhD, and Andrew Cope, MD, PhD BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a …
Alzamend Neuro Announces Reverse Stock Split
GlobeNewswire
·
May 8, 2025
ATLANTA, May 08, 2025 (GLOBE NEWSWIRE) -- Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend” or the “Company”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”), bipolar …
AskBio Announces 15 Presentations at American Society of Gene and Cell Therapy 28th Annual Meeting
GlobeNewswire
·
May 8, 2025
Research Triangle Park, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- Three oral and 12 poster presentations demonstrate breadth and progress of AskBio’s gene therapy research and development activities, as well as advancements in manufacturing capabilities …
PL BioScience Raises the Bar in Cell Culture Technology with First Artificial Human Platelet Lysate Worldwide
GlobeNewswire
·
May 8, 2025
Worldwide first artificial Human Platelet Lysate (HPL) solution – a key ingredient for the research …
Pathos AI Appoints Iker Huerga as Chief Executive Officer to Lead the Next Era of AI-Enabled Drug Development
GlobeNewswire
·
May 8, 2025
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Pathos AI, a leading AI-enabled biotech company focused on transforming drug development in oncology, today announced the appointment of Iker Huerga as Chief Executive Officer and Board Member. Huerga brings over …
Stryker declares an $0.84 per share quarterly dividend
GlobeNewswire
·
May 8, 2025
Portage, Michigan, May 08, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable July 31, 2025, to shareholders of record at the close of business on June 30, 2025, …
Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates
GlobeNewswire
·
May 8, 2025
Conference call and webcast on Monday, May 12, 2025, at 2:30 p.m. PT / 5:30 p.m. ET REDWOOD CITY, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a biopharmaceutical company developing novel immunotherapies for the treatment …
Caliber Receives Design Review Approval for PURE Pickleball & Padel Project
GlobeNewswire
·
May 8, 2025
SCOTTSDALE, Ariz., May 08, 2025 (GLOBE NEWSWIRE) -- Caliber (NASDAQ: CWD), a real estate investor, developer, and manager, today announced that its joint venture development, PURE Pickleball …
The Brain Song Reviews: Can This 7-Minute Memory Boosting Soundwave Help With Anti-Aging Benefits?
GlobeNewswire
·
May 8, 2025
WILMINGTON, Del., May 08, 2025 (GLOBE NEWSWIRE) -- In today’s world of constant digital distractions, overwhelming stress, and information overload, maintaining optimal cognitive performance is more crucial than ever. Whether you're a student gearing up …
Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance
GlobeNewswire
·
May 8, 2025
Record First Quarter MACI Revenue of $46.3 Million and First Quarter Total Revenue of $52.6 Million Approximately 400 MACI Arthro Surgeons Trained to Date, with Year-to-Date Biopsy Growth Over 30% for Trained Surgeons Second Quarter Total Revenue and MACI …
Aqua Sculpt Complaints Explained: May 2025 User Reviews Analysed And Verified (Ice Water Hack for Weight Loss)
GlobeNewswire
·
May 8, 2025
TAMPA, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Here’s What You’ll Learn in This Article What Is AquaSculpt? Discover How the “Ice Water Hack” Taps Into Hydration-Driven Fat Loss Who Should Use a Stimulant-Free Fat Burner—and Why AquaSculpt Stands Out Real …
SlimJaro Reviews [We Tested It] FDA-Registered, GMP-Certified Weight Loss Solution
GlobeNewswire
·
May 8, 2025
Discover the truth about SlimJaro in our detailed review! We tested SlimJaro Pro, the natural weight loss supplement made in FDA-registered, GMP-certified facilities, and reveal everything you need to know — from ingredients and benefits to real customer …
Free Sugar Pro Drops Reviews [Doctor Recommended] Best Glycogen Blood Balance Support Formula
GlobeNewswire
·
May 8, 2025
AURORA, Colo., May 08, 2025 (GLOBE NEWSWIRE) -- Introduction to Free Sugar Pro Drops Free Sugar Pro Drops chronic health conditions like diabetes and obesity are on the rise, managing blood sugar levels has become a critical aspect of maintaining overall …
OrganOx Announces Second Private Placement Closing, Investments by Intuitive Ventures and Terumo Ventures
GlobeNewswire
·
May 8, 2025
OXFORD, England and MADISON, N.J., May 08, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd., a leading organ medical technology company, completed a second closing of its private placement with investments from Intuitive Ventures, Terumo Ventures, and Piper Heartland …
Cognition Therapeutics Reports Topline Results Showing Oral Zervimesine (CT1812) Reduced Lesion Growth in Phase 2 Study in Geographic Atrophy
GlobeNewswire
·
May 8, 2025
Zervimesine treatment slowed the rate of GA lesion growth by 28.6% compared to placebo Observed GA lesion area was reduced by 28.2% at 18 months compared to placebo Dry AMD results validate zervimesine’s potential across degenerative disease indications …
Kamari Pharma Announces Presentations at the 82nd Annual Meeting of the Society for Investigative Dermatology and the International Pachyonychia Congenita Consortium Symposium
GlobeNewswire
·
May 8, 2025
Preclinical results presented demonstrate KM-023 is a highly effective and selective oral TRPV3 inhibitor KM-023 normalized cells proliferation and differentiation in 3D pachyonychia congenita skin model and significantly reduced itch behavior and …